AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MeVis Medical Solutions AG

Prospectus Nov 5, 2007

287_rns_2007-11-05_ce7288d7-11e3-4734-be37-659c142b81e8.html

Prospectus

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 5 November 2007 08:23

MeVis Medical Solutions AG: MeVis Medical Solutions AG fixes offering period and price range for IPO

MeVis Medical Solutions AG / IPO

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


Bremen, November 5, 2007 - MeVis Medical Solutions Aktiengesellschaft,
together with the syndicate banks M.M.Warburg & CO (Lead Manager /
Bookrunner) and Landesbank Baden-Württemberg (Co-Lead Manager), today have
fixed the price range within which investors can bid in the context of the
planned IPO for the up to 776.866 shares in the company, at EUR 55.00 to
EUR 65.00 per share. The offering period starts on November 7, 2007 and
will end on November 14, 2007 at 11:00 (CET) for private investors and at
13:00 (CET) for institutional investors. All further terms and conditions
of the offering are contained in the approved prospectus available for
download at www.mevis.de.

Additional information:
ISIN: DE000A0LBFE4
WKN: AOLBFE

Admission applied for: Prime Standard segment; Frankfurt Stock Exchange

Helmut Kranzmaier
Mobil: +49 172 899 6267
Email: [email protected]

05.11.2007 Financial News transmitted by DGAP

Language: English
Issuer: MeVis Medical Solutions AG
Universitätsallee 29
28359 Bremen
Deutschland
Phone: +49 421 330 74-0
Fax: +49 421 330 74-50
E-mail: [email protected]
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE

Notierung vorgesehen / Designated to be listed: Regulierter Markt in Frankfurt (Prime Standard)

End of News DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.